期刊文献+

非维生素K拮抗剂类口服抗凝药抗凝活性实验室监测的研究进展 被引量:2

Research progress of laboratory monitoring of non-vitamin K antagonist oral anticoagulants
原文传递
导出
摘要 相较于传统的维生素K拮抗剂类口服抗凝药,非维生素K拮抗剂类口服抗凝药由于疗效确切和出血风险小等优点,近年来越来越多地被应用于房颤及深静脉血栓的抗凝治疗中。尽管通常认为此类药物不需常规监测国际标准化比值(INR),但在某些特定情况下如紧急手术前和出血等,抗凝疗效评估及安全监测必不可少。部分常规的实验室监测指标已被证实敏感且特异性较好,但仍缺乏统一的标准。一些新的实验室检测手段及即时检测手段近年来也发展迅速。通过对近年来非维生素K拮抗剂类口服抗凝药实验室监测的研究进展进行综述,为临床医师及药师安全用药提供参考。
作者 袁媛 赵永红 王斌 YUAN Yuan;ZHAO Yonghong;WANG Bin
出处 《中国临床药学杂志》 CAS 2019年第6期473-477,共5页 Chinese Journal of Clinical Pharmacy
基金 上海市静安区医学科研青年课题(编号2018QN02) 上海市医疗机构临床药学重点专科建设项目
  • 相关文献

参考文献3

二级参考文献13

  • 1Society of Cardiology, Chinese Medical Association.Retrospective investigation of hospitalized patients with atrial fibrillation in China's Mainland[J].Chinese Medical Journal,2004,17(12):1763-1767. 被引量:23
  • 2王小艳.急性冠脉综合征后6个月死亡和心肌梗死的预测:前瞻性的多国观察性研究(GRACE)[J].中国处方药,2006(11):25-26. 被引量:138
  • 3Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke : the Framingham Study[ J]. Stroke, 1991,22(8) : 983.
  • 4Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation [ J]. Ann Intern Med, 2007, 146(12):857.
  • 5Hylek EM, Evans-molina C, Shea C, et al. Major hemorrhage and tol- erability of warfarin in the first year of therapy among elderly patients with atrial fibrillation[J]. Circulation, 2007, 115(21): 2689.
  • 6Connolly SJ, Pogue J, Eikelboom J, et al. ACTIVEW Investigators. Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range[ J]. Circulation, 2008, 118(20): 2029.
  • 7] Castelli R, Porro F, Savo D, et al. New antithrombotic agents[ J ]. Pan- minerva Med, 2006, 48(4) : 247.
  • 8Higgins JPT, Ahman DG. General methods for Cochrane reviews. In: Higgins JPT, Green S, editors. Cochrane handbook for systematic re- views of interventions[EB/OL]. London: John Wiley & Sons, Ltd, 2008 : 81.
  • 9Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation[J]. N Engl J Med, 2009, 361(12): 1139.
  • 10Granger CB, Alexander JH, McMurray JJ, et al. Apixaban versus war- farin in patients with atrial fibrillation[J]. N Engl J Med, 2011, 365 (11): 981.

共引文献94

同被引文献6

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部